MedTrace Logo

Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.

NCT00358839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2006-11-10

No results posted yet for this study

Summary

The aim of the present study is to explore functional consequences of migraine gene mutations on their responses to Calcitonin Gene Related Peptide (CGRP)infusion.

Conditions

  • Familial Hemiplegic Migraine

Interventions

DRUG

CGRP

Sponsors & Collaborators

  • EUROHEAD

    collaborator OTHER

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Jakob Møller Hansen, MD · Danish Headache Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
ECT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Completion
2006-10-31

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00358839 on ClinicalTrials.gov